These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 21466977)
21. The influence of the suppression of gastrooesophageal reflux on the gene expression pattern in Barrett's oesophagus. Menges M; Michaeli B; Pueschel W; Zeitz M; Meese E Int J Oncol; 2002 Jun; 20(6):1323-9. PubMed ID: 12012017 [TBL] [Abstract][Full Text] [Related]
22. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma. Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457 [TBL] [Abstract][Full Text] [Related]
24. Duodeno-gastric-esophageal reflux--what is pathologic? Comparison of patients with Barrett's esophagus and age-matched volunteers. Wolfgarten E; Pütz B; Hölscher AH; Bollschweiler E J Gastrointest Surg; 2007 Apr; 11(4):479-86. PubMed ID: 17436133 [TBL] [Abstract][Full Text] [Related]
25. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546 [TBL] [Abstract][Full Text] [Related]
26. Barrett's oesophagus: a clinical study of 52 patients. Cooper BT; Barbezat GO Q J Med; 1987 Feb; 62(238):97-108. PubMed ID: 3498962 [TBL] [Abstract][Full Text] [Related]
27. The role of acid and bile reflux in oesophagitis and Barrett's metaplasia. Souza RF Biochem Soc Trans; 2010 Apr; 38(2):348-52. PubMed ID: 20298181 [TBL] [Abstract][Full Text] [Related]
28. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
29. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Song S; Guha S; Liu K; Buttar NS; Bresalier RS Gut; 2007 Nov; 56(11):1512-21. PubMed ID: 17604323 [TBL] [Abstract][Full Text] [Related]
30. Leptin and the risk of Barrett's oesophagus. Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC; Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609 [TBL] [Abstract][Full Text] [Related]
31. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Dvorak K; Payne CM; Chavarria M; Ramsey L; Dvorakova B; Bernstein H; Holubec H; Sampliner RE; Guy N; Condon A; Bernstein C; Green SB; Prasad A; Garewal HS Gut; 2007 Jun; 56(6):763-71. PubMed ID: 17145738 [TBL] [Abstract][Full Text] [Related]
32. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus. Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384 [TBL] [Abstract][Full Text] [Related]
34. A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients. Csendes A; Braghetto I; Burdiles P; Díaz JC; Maluenda F; Korn O Ann Surg; 1997 Aug; 226(2):123-33. PubMed ID: 9296504 [TBL] [Abstract][Full Text] [Related]
35. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. Lin OS; Schembre DB; Mergener K; Spaulding W; Lomah N; Ayub K; Brandabur JJ; Bredfeldt J; Drennan F; Gluck M; Jiranek GC; McCormick SE; Patterson D; Kozarek RA Gastrointest Endosc; 2007 Apr; 65(4):577-83. PubMed ID: 17324414 [TBL] [Abstract][Full Text] [Related]
36. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus. Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565 [TBL] [Abstract][Full Text] [Related]
37. Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus. Laheij RJ; Van Rossum LG; De Boer WA; Jansen JB Aliment Pharmacol Ther; 2002 May; 16(5):887-91. PubMed ID: 11966496 [TBL] [Abstract][Full Text] [Related]
38. Young patients with Barrett's oesophagus experience less reflux complaints. Loffeld RJ Digestion; 2001; 64(3):151-4. PubMed ID: 11786662 [TBL] [Abstract][Full Text] [Related]